ISRCTN96631607已完成不适用
Early Diabetes Intervention Trial
Bayer plc and Merck-Lipha (UK)0 个研究点目标入组 631 人开始时间: 2002年6月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 631
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Subjects aged 30 to 70 years inclusive, with fasting hyperglycaemia; defined as a fasting plasma glucose (FPG) level =5.5 mmol/l and <7.8 mmol/l on two occasions at least 1 week apart
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
4 期
DIAbetes-PREvention Trialpre-diabeticiHeart problemspre-diabetics10011082NL-OMON38088Isala Klinieken78
进行中（未招募）
不适用
Diabetes-Prevention TrialPatients who are candidates for cardiac rehabilitation after documented coronairy artery disease (PCI or CABG in stable CAD, or post STEMI and post non-STEMI), who have pre-diabetesMedDRA version: 14.1Level: LLTClassification code 10064346Term: STEMISystem Organ Class: 100000004849MedDRA version: 14.1Level: LLTClassification code 10036482Term: Pre-diabeticSystem Organ Class: 100000004861EUCTR2011-002469-39-NLIsala Klinieken
进行中（未招募）
不适用
Testing a non-invasive smartphone application to predict sugar levels in the bloodISRCTN15977623Bioepic Ltd72
尚未招募
2 期
Pilot Clinical Trial for Treatment of Diabetic Foot Ulcers with Dietary Nano-formulated Phytochemicalsdiabetic foot ulcersMetabolic and Endocrine - DiabetesACTRN12610000565044CamMedica, Ltd.35
进行中（未招募）
不适用
Early Prevention of Diabetes Complications in people with Pre-Diabetes in Europeon diabetic hyperglycaemia:Impaired Glucose Tolerance (IGT) or Impaired Fasting Glucose (IFG) or bothMedDRA version: 17.1Level: LLTClassification code 10065542Term: PrediabetesSystem Organ Class: 100000004861EUCTR2013-000418-39-ESFUNDACION DE INVESTIGACION EN RED EN ENFERMEDADES CARDIOVASCULARES (FIRCAVA)3,000